Andy I'm asking your opinion on one query. If multikane only works on those who had not received chemo wouldn't that mean that those, who today, had recieved chemo cannot receive multikane. However, in the future all those who plan on recieving chemo will, instead, just use multikane. Effectively bringing that 60% endpoint in the same category as the current 40% endpoint that passed? I hope I worded that in a way that makese sense.
You left out the minor detail that the trial failed its only primary endpoint. The company disclosed no actual data on its data-dredging exercise. CEO hilariously (and falsely) claiming that they can't disclose data due to "journals" lol!
Thanks Andy for your work on another one of your excellent articles. And it is really fair of you to note that you did predict that there was a possible grayzone and that's where we are. And thanks to the good work of you and frugal I'm staying long and strong. Just shifting my time frames a bit. Your work is much appreciated.
Andy I'm asking your opinion on one query. If multikane only works on those who had not received chemo wouldn't that mean that those, who today, had recieved chemo cannot receive multikane. However, in the future all those who plan on recieving chemo will, instead, just use multikane. Effectively bringing that 60% endpoint in the same category as the current 40% endpoint that passed? I hope I worded that in a way that makese sense.
You left out the minor detail that the trial failed its only primary endpoint. The company disclosed no actual data on its data-dredging exercise. CEO hilariously (and falsely) claiming that they can't disclose data due to "journals" lol!
Thanks Andy for your work on another one of your excellent articles. And it is really fair of you to note that you did predict that there was a possible grayzone and that's where we are. And thanks to the good work of you and frugal I'm staying long and strong. Just shifting my time frames a bit. Your work is much appreciated.
'Potential secondary benefits (e.g. tumor reduction, quality of life) to come', when is this coming ?